University of Michigan Hemophilia and Coagulation Disorders — Ann Arbor, Michigan

University of Michigan Hemophilia and Coagulation Disorders is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Michigan Hemophilia and Coagulation Disorders has participated in 2 clinical trials.

Therapeutic areas: Hemophilia, Hemophilia A, Hemophilia B.

Sponsors: American Thrombosis and Hemostasis Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ann Arbor

Browse all research sites in Michigan · View every site in Ann Arbor

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Hemophilia and Coagulation Disorders?

University of Michigan Hemophilia and Coagulation Disorders has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Hemophilia and Coagulation Disorders conducted?

University of Michigan Hemophilia and Coagulation Disorders has 2 clinical trials on record. Their work covers Hemophilia, Hemophilia A, Hemophilia B.

Is University of Michigan Hemophilia and Coagulation Disorders accredited by Crixeo Clinical Trials?

University of Michigan Hemophilia and Coagulation Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Hemophilia and Coagulation Disorders?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.